Share on StockTwits

Columbia Laboratories (NASDAQ:CBRX) CEO Frank Condella, Jr. bought 10,000 shares of the stock on the open market in a transaction dated Wednesday, August 13th. The stock was purchased at an average price of $5.98 per share, for a total transaction of $59,800.00. Following the transaction, the chief executive officer now directly owns 55,345 shares of the company’s stock, valued at approximately $330,963. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link.

Columbia Laboratories (NASDAQ:CBRX) opened at 5.94 on Monday. Columbia Laboratories has a one year low of $5.59 and a one year high of $8.37. The stock has a 50-day moving average of $6.24 and a 200-day moving average of $6.65. The company has a market cap of $64.0 million and a P/E ratio of 30.20.

Columbia Laboratories (NASDAQ:CBRX) last issued its quarterly earnings data on Thursday, July 31st. The company reported $0.01 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.11 by $0.10. On average, analysts predict that Columbia Laboratories will post $0.16 earnings per share for the current fiscal year.

Columbia Laboratories, Inc (NASDAQ:CBRX) focuses on developing products that utilize its bioadhesive drug delivery technologies to optimize drug delivery in a controlled, sustained manner.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.